Development of non-viral vectors for systemic gene delivery
- 25 December 2001
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 78 (1-3) , 259-266
- https://doi.org/10.1016/s0168-3659(01)00494-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Improving plasmid DNA-mediated liver gene transfer by prolonging its retention in the hepatic vasculatureThe Journal of Gene Medicine, 2001
- Transfer of Full-Length Dmd to the Diaphragm Muscle of Dmdmdx/mdx Mice through Systemic Administration of Plasmid DNAMolecular Therapy, 2001
- Sequential Injection of Cationic Liposome and Plasmid DNA Effectively Transfects the Lung with Minimal Inflammatory ToxicityMolecular Therapy, 2001
- DNA activates human immune cells through a CpG sequence‐dependent mannerImmunology, 1999
- Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNAGene Therapy, 1998
- Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene deliveryGene Therapy, 1998
- Protamine sulfate enhances lipid-mediated gene transferGene Therapy, 1997
- Influence of Membrane-Active Peptides on Lipospermine/DNA Complex Mediated Gene TransferBioconjugate Chemistry, 1997
- Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,Biochemistry, 1996
- α-Helix–double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine modelNature, 1978